INKEF Capital

General information

HQ

Amsterdam, Noord-Holland

Description

INKEF Capital was established in 2010 to finance and support starting entrepreneurs and their spectacular technology ventures. INKEF is short for Investing in the Knowledge Economy of the Future. More collaborator than investor, we prefer to contribute early but partner long-term, guiding young companies from series A capital and through subsequent financing rounds, always with the intention of steering them towards success.

Team

Michael Stam (CEO), Dirk Kersten (Managing Director), Robert Jan Galema (Managing Director), Jan Keltjens (Senior Director), Patrick Vink (Senior Director), Lucas de Breed (Director), Corne Jansen (Director), Kyang Yung (Director), Thijs Cohen Tervaert (Associate), Mirella Tempelaars (Operations Manager), Janneke van Dongen (Office Manager)

Socials

Contact information

Investment information

Investment type

Early stage venture investments

Investment size

500K – 5M+

Investing in

Healthcare, ICT, New Media and FinTech

Investments made

Aito, Bloomon, Audion, Crowdynews, EclecticIQ, Therapeutics, GeoPhy, InteRNA, NightBalance, NPEX, Robin, Shapeways, Veenhof, ViCentra, Wercker

Exits

Lanthio Pharma (Acquired by Morphosys), ProFibrix (Acquired by The Medicines Company), Sapiens (Acquired by Medtronic)